Search Results 1181-1190 of 16040 for melatonin receptor agonists
About this study. The purpose of this study is: To Evaluate and validate the Roche Coaguchek XS Plus analyzer at MCA to replace the ITC Hemochron Jr.
The purpose of this study is to estimate the recommended phase II dose (RP2D) of venetoclax that can be combined with standard dose Dd combination (Arm A), Rd ...
Eric Moore, M.D., Department of Otolaryngology, Head and Neck Surgery, Mayo Clinic: We specialize in rare cancers so that they're common for us. You come and ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this study is to determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with ...
Ritlecitinib is used to treat severe alopecia areata (autoimmune disorder that causes patchy hair loss). This medicine is a Janus kinase 3 (JAK3) and tyrosine ...
Mayo Clinic researcher Katherine H. Noe, M.D., investigates evaluation methods, quality and safety, and management of adult patients with epilepsy.
Erlotinib is used for the treatment of metastatic (cancer that has already spread) non-small cell lung cancer in patients who have certain types of abnormal ...
The purpose of Part I of the study is to assess the efficacy and safety of MK-8931 compared with placebo administered for 78 weeks in the treatment of ...
The purpose of the study is to learn more about autoimmunity and potential mother to baby transmission of pathogenic antibodies.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 3 to double your impact.